Is Glaukos Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Glaukos Corp (GKOS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Glaukos Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Glaukos Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Glaukos Corp?

Muslim investors may consider investing in Glaukos Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Glaukos Corp classified as HALAL?

Musaffa determines the Shariah status of Glaukos Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Glaukos Corp updated?

The Shariah compliance status of Glaukos Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Glaukos Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Glaukos Corp?

You can check the latest Shariah compliance status of Glaukos Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

GKOS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 26, 2026

Report Source: 2025 Annual Report

Glaukos Corp. Stock Analysis GKOS

United States Health Care Mid Cap Report: 2025 Annual

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is headquartered in Aliso Viejo, California and currently employs 1,094 full-time employees. The company went IPO on 2015-06-25. The firm is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.

Key Statistics of Glaukos Corp (GKOS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$140.91$144.16

Today's Open

$142.27

Volume

978.75K

P/E Ratio (TTM)

52 Week Range

$73.16$146.75

Market Cap

7.84B

Avg. Volume

776.22K

Dividend Yield

Financial Metrics & Statements of Glaukos Corp (GKOS)

FAQ's for Glaukos Corp (GKOS)

According to Musaffa’s Shariah screening methodology, Glaukos Corp (GKOS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.